Publication date: Sep 19, 2024
Implantable Collamer Lense (ICL) presents a viable alternative to conventional refractive surgeries, but their impact on corneal microstructure remains unclear. By employing in vivo confocal microscopy (IVCM), we examined changes in stromal and endothelial cells following the insertion of V4c ICLs, with the goal of enhancing post-surgical care and outcomes. In this longitudinal investigation, we conducted detailed preoperative assessments on 103 eyes from 53 participants. Follow-up evaluations were carried out after surgery at set intervals: one day, one week, one month, three months, six months, and twelve months. We used IVCM to analyze changes in stromal and endothelial cells. To assess differences between pre- and post-surgery variables and to investigate correlations with age, axial length (AL), and spherical equivalent refraction (SER), we applied a repeated measures mixed-effects model, with statistical significance set at P
Open Access PDF
Concepts | Keywords |
---|---|
Month | Confocal microscopy |
Refraction | Endothelial cell density |
Surgery | Implantable collamer lens |
V4c | Myopia correction |
Vivo | Refractive surgery |
Semantics
Type | Source | Name |
---|---|---|
drug | DRUGBANK | Serine |
pathway | REACTOME | Reproduction |
drug | DRUGBANK | Coenzyme M |
disease | MESH | complications |
drug | DRUGBANK | Esomeprazole |
disease | IDO | quality |
disease | MESH | lens opacities |
disease | MESH | fibrosis |
disease | MESH | refractive error |
disease | MESH | ocular infections |
disease | MESH | inflammations |
disease | IDO | history |
disease | MESH | hypersensitivities |
disease | MESH | corneal diseases |
disease | MESH | Myopia |
drug | DRUGBANK | Oxybuprocaine |
drug | DRUGBANK | Medical air |
disease | IDO | object |
drug | DRUGBANK | Cysteamine |
drug | DRUGBANK | Aspartame |
disease | MESH | glaucoma |
disease | MESH | keratoconus |
disease | IDO | cell |